Device Trial Radar · NCT05396495
Safety and Feasibility of the NeurolyserXR for Sacroiliac Joint Pain
Last checked: Nov 20, 2026Latest source record: Nov 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
10
Planned (sponsor's estimate)
Start
Sep 24, 2024
Primary completion
May 1, 2027
Study completion Jul 1, 2027
Sponsor
- Lead sponsor
- FUSMobile Inc.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- Sheba Medical Center
- First posted
- May 31, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Pilot study to evaluate the safety and the effectiveness of the Neurolyser XR as a treatment for sacroiliitis
Conditions
- Sacroiliitis
Interventions
NeurolyserXRDevice
Using the NeurolyserXR to non-invasively ablate the posterior sacral branches enervating the sacroiliac joint
Primary outcomes
What the sponsor says the trial is designed to measure.
- Effectiveness per pain score using numerical rating scale of 0 to 10Time frame: Baseline throughout the follow-up period of six months
- Safety per adverse eventsTime frame: Baseline throughout the follow-up period of six months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Sheba Medical Center
Giv‘atayim, Israel
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.